Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04267783
Other study ID # 2018-02267
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 1, 2019
Est. completion date May 30, 2020

Study information

Verified date August 2020
Source Centre Hospitalier Universitaire Vaudois
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Prospective study evaluating the feasibility of shear-wave elastography of the uterus during the third stage of labour and following placental delivery. The investigators hypothesize that the stiffness of the myometrium can be measured by using shear-wave technology. This study involves 30 patients with a healthy pregnancy and spontaneous vaginal delivery. One co-investigator will carry out measurements at the uterine fundus, at three different time points: after fetal delivery, after placental delivery and 30 minutes after placental delivery.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date May 30, 2020
Est. primary completion date April 30, 2020
Accepts healthy volunteers
Gender Female
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

- singleton pregnancy

- cephalic presentation

- maternal age > 18 years old

- nulliparous

- healthy uncomplicated pregnancy

- gestational age between 37-42 weeks of gestation

- spontaneous labour and delivery

- uncomplicated progression of labour (cervical dilatation at >1 cm/h)

- administration of less than 3 units of oxytocin during the second stage of labour

- patient having read, accepted and signed the consent form

Exclusion Criteria:

- antepartum hemorrhage in the present pregnancy

- protracted second stage of labour (more than two hours from full dilatation to delivery)

- more than 30 minutes of active pushing

- BMI > 35 kg/m2

- distance from skin to uterus > 8 cm

- age > 35 years old

- instrumental deliveries

- bleeding disorders

- polyhydramnios

- diabetes

- pre-eclampsia

- high blood pressure

- use of anticoagulant medications

- clinical chorioamnionitis

- placental abnormality (low-lying or abruption)

- fetal macrosomia

- uterine fibroids

- uterine anomalies

- previous uterine scar

- multiple pregnancy

- placental retention

- inability to follow procedures or insufficient knowledge of project language

- inability to give consent

- refusal to participate

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Shear wave elastography
Investigate the feasibility of use of shear-wave elastography of the uterus during the third stage of labour and following placental delivery in order to predict uterine atony .

Locations

Country Name City State
Switzerland University Hospital of Lausanne Lausanne Vaud

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire Vaudois

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Stiffness of the myometrium Difference in median myometrial shear wave velocity between each time point: after fetal delivery, after placental delivery and 30 minutes after placental delivery. Third labor stage to 30 minutes post placenta delivery
Secondary Blood loss Measurement of total blood loss Two hours following the childbirth
See also
  Status Clinical Trial Phase
Completed NCT03434444 - In Vitro Optimization of Oxytocin-induced Myometrial Contractility by Propranolol N/A
Terminated NCT01980173 - Medico-economic Comparison of Postpartum Hemorrhage Management Using the Bakri Balloon and Standard Care N/A
Not yet recruiting NCT06033170 - Celox™ PPH for Reaching Haemostasis in Patients With Postpartum Hemorrhage N/A
Completed NCT02163616 - Treatment of Postpartum Hemorrhage With Misoprostol: Fever Study Phase 3
Not yet recruiting NCT02319707 - Management of the Third Stage of Labor Phase 3
Recruiting NCT01600612 - Oxytocin, Carbetocin and Misopristol for Treatment of Postpartum Hemorrhage: A Multicentric Randomized Trial N/A
Completed NCT02079558 - Efficacy of Oxytocin vs. Carbetocin in Prevention of Postpartum Hemorrhage After Cesarean Section Phase 2
Withdrawn NCT01108302 - Effectiveness, Safety and Feasibility of Auxiliary Nurse Midwives' (ANM) Use of Oxytocin in Uniject™ to Prevent Postpartum Hemorrhage in India N/A
Completed NCT00097123 - RCT of Misoprostol for Postpartum Hemorrhage in India N/A
Completed NCT02883673 - Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage N/A
Completed NCT02542813 - Safety, Tolerability and Pharmacokinetics (PK) Study of Oxytocin (GR121619) Administered Via an Inhaled Route in Healthy Female Volunteers Phase 1
Completed NCT04201665 - EMG for Uterotonic Efficiency Estimation N/A
Terminated NCT03246919 - Ideal Time of Oxytocin Infusion During Cesarean Section Phase 4
Not yet recruiting NCT05501106 - Reducing Postpartum Hemorrhage After Vaginal Delivery N/A
Completed NCT05429580 - Prophylactic Tranexamic Acid Use After Vaginal Delivery N/A
Terminated NCT03064152 - Rotational Thromboelastometry for the Transfusion Management of Postpartum Hemorrhage After Vaginal or Cesarean Delivery N/A
Recruiting NCT05382403 - Novel Vacuum-Induced Hemorrhage Control for Postpartum Hemorrhage N/A
Completed NCT03344302 - Oxytocin Administration During Cesarean Section Phase 4
Completed NCT02910310 - Introduction of UBT for PPH Management in Three Countries N/A
Completed NCT02805426 - Effectiveness of Tranexamic Acid When Used as an Adjunct to Misoprostol for the Treatment of Postpartum Hemorrhage Phase 4